Pharmacological and proteomic analyses of neonatal polyI:C-treated adult mice

Kanako Kitagawa1, Taku Nagai1, Kiyofumi Yamada1

  • 1Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan.

Neuroscience Research
|August 27, 2019
PubMed

Insights

Neonatal viral infection models, like polyI:C exposure in mice, show promise for studying neurodevelopmental disorders. Antipsychotics like clozapine demonstrate potential in ameliorating associated behavioral deficits.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Perinatal viral infections are linked to neurodevelopmental disorders, including schizophrenia.
  • Neonatal exposure to polyriboinosinic-polyribocytidilic acid (polyI:C), a viral mimetic, induces adolescent behavioral and cognitive deficits in mice.
  • Understanding the impact of immune activation on brain development is crucial for identifying therapeutic targets.

Purpose of the Study:

  • To investigate the efficacy of antipsychotic medications in ameliorating polyI:C-induced behavioral abnormalities in a mouse model.
  • To identify molecular changes in the hippocampus associated with neonatal immune activation using proteomic analysis.
  • To explore the potential of this model for evaluating novel antipsychotic compounds.

Main Methods:

  • Neonatal mice received daily subcutaneous injections of polyI:C from postnatal day 2 to 6.
  • At 10 weeks of age, behavioral tests assessed sensorimotor gating, emotional regulation, and cognitive function.
  • Hippocampal proteomic analysis was performed using two-dimensional electrophoresis on polyI:C-treated adult mice.

Main Results:

  • Clozapine treatment improved prepulse inhibition (PPI) deficits, as well as emotional and cognitive dysfunctions in polyI:C-exposed mice.
  • Haloperidol treatment solely improved the PPI deficit in the polyI:C model.
  • Proteomic analysis identified aldehyde dehydrogenase family 1 member L1 (ALDH1L1) and collapsin response mediator protein 5 (CRMP5) as differentially expressed proteins in the hippocampus.

Conclusions:

  • The polyI:C mouse model is a valuable tool for assessing the antipsychotic potential of therapeutic agents.
  • Altered expression of ALDH1L1 and CRMP5 suggests a role for astrocyte-neuron interactions in the neurodevelopmental consequences of neonatal immune activation.
  • These findings contribute to understanding the pathophysiology of neurodevelopmental disorders triggered by early-life immune challenges.

Related Concept Videos

Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
9.4K
Cholinergic Antagonists: Pharmacological Actions01:28

Cholinergic Antagonists: Pharmacological Actions

Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.6K
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.2K
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.4K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
694
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
538